###begin article-title 0
Insulin Gene Expression Is Regulated by DNA Methylation
###end article-title 0
###begin p 1
Conceived and designed the experiments: AK TR KF. Performed the experiments: AK IT KF. Analyzed the data: AK IT KF. Contributed reagents/materials/analysis tools: HTK IHAA YM. Wrote the paper: AK HTK FK YM GPP KF.
###end p 1
###begin p 2
Current address: Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Suita-City, Japan
###end p 2
###begin p 3
Current address: Department of Orthopedic Surgery, Rush University Medical Center, Chicago, Illinois, United States of America
###end p 3
###begin title 4
Background
###end title 4
###begin p 5
###xml 430 435 <span type="species:ncbi:10090">mouse</span>
###xml 440 445 <span type="species:ncbi:9606">human</span>
Insulin is a critical component of metabolic control, and as such, insulin gene expression has been the focus of extensive study. DNA sequences that regulate transcription of the insulin gene and the majority of regulatory factors have already been identified. However, only recently have other components of insulin gene expression been investigated, and in this study we examine the role of DNA methylation in the regulation of mouse and human insulin gene expression.
###end p 5
###begin title 6
Methodology/Principal Findings
###end title 6
###begin p 7
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 175 178 175 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
###xml 570 578 570 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 616 623 616 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 721 725 721 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 888 896 888 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 154 159 <span type="species:ncbi:10090">mouse</span>
###xml 169 174 <span type="species:ncbi:9606">human</span>
###xml 734 739 <span type="species:ncbi:10090">mouse</span>
Genomic DNA samples from several tissues were bisulfite-treated and sequenced which revealed that cytosine-guanosine dinucleotide (CpG) sites in both the mouse Ins2 and human INS promoters are uniquely demethylated in insulin-producing pancreatic beta cells. Methylation of these CpG sites suppressed insulin promoter-driven reporter gene activity by almost 90% and specific methylation of the CpG site in the cAMP responsive element (CRE) in the promoter alone suppressed insulin promoter activity by 50%. Methylation did not directly inhibit factor binding to the CRE in vitro, but inhibited ATF2 and CREB binding in vivo and conversely increased the binding of methyl CpG binding protein 2 (MeCP2). Examination of the Ins2 gene in mouse embryonic stem cell cultures revealed that it is fully methylated and becomes demethylated as the cells differentiate into insulin-expressing cells in vitro.
###end p 7
###begin title 8
Conclusions/Significance
###end title 8
###begin p 9
Our findings suggest that insulin promoter CpG demethylation may play a crucial role in beta cell maturation and tissue-specific insulin gene expression.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 318 322 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins1</italic>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 369 373 369 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 470 474 470 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins1</italic>
###xml 577 581 577 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 616 619 616 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Wentworth1">[1]</xref>
###xml 627 631 627 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 641 645 641 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins1</italic>
###xml 674 677 674 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Palumbo1">[2]</xref>
###xml 688 691 688 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Deltour1">[3]</xref>
###xml 705 708 705 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Leighton1">[4]</xref>
###xml 720 723 720 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Lamotte1">[5]</xref>
###xml 795 799 795 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 814 817 814 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
###xml 847 851 847 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins1</italic>
###xml 894 897 894 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Moore1">[6]</xref>
###xml 954 957 954 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Caspary1">[7]</xref>
###xml 959 962 959 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Duvilli1">[8]</xref>
###xml 1019 1022 1019 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Bennett1">[9]</xref>
###xml 1113 1117 1113 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Feil1">[10]</xref>
###xml 1119 1123 1119 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Vu1">[11]</xref>
###xml 277 282 <span type="species:ncbi:10090">mouse</span>
###xml 621 626 <span type="species:ncbi:10090">Mouse</span>
###xml 764 769 <span type="species:ncbi:9606">human</span>
###xml 808 813 <span type="species:ncbi:9606">human</span>
Insulin is a master regulator of metabolic homeostasis and it is secreted from pancreatic beta cells in response to nutrient stimulation. Insulin gene expression begins early in the embryonic development of the pancreas and remains tightly-regulated throughout adult life. The mouse genome contains two insulin genes, Ins1 (GeneID: 16333) and Ins2 (GeneID: 16334). The Ins2 gene has greater structural and functional similarity to other mammalian insulin genes, whereas Ins1 is considered to be a functional retroposon since it possesses only one of the two introns present in Ins2 and other mammalian insulin genes [1]. Mouse Ins2, but not Ins1, is expressed in the thymus [2], yolk sac [3], fetal liver [4], and brain [5] as well as the pancreas, similar to the human gene. Additionally, both Ins2 and the human INS (GeneID: 3630) gene, but not Ins1, are paternally imprinted in the yolk sac [6] in association with the H19/Igf2 imprint control region [7], [8], but exhibit biallelic expression in the adult pancreas [9]. Since imprinting of this region is associated with differential DNA methylation patterns [10], [11], we hypothesized that insulin gene expression may be regulated by DNA methylation.
###end p 11
###begin p 12
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Baylin1">[12]</xref>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Robertson1">[13]</xref>
###xml 401 405 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Jirtle1">[14]</xref>
###xml 532 536 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-TurekPlewa1">[15]</xref>
###xml 683 687 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Hay1">[16]</xref>
###xml 1044 1048 1044 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Faideau1">[17]</xref>
Mammalian gene promoters contain cytosine-guanosine dinucleotide (CpG) sites which play a pivotal role in the control of gene expression [12], [13]. Methylation of the cytosine residues regulates transcription directly by inhibiting the binding of specific transcription factors, and indirectly by recruiting methyl-CpG-binding proteins and their associated repressive chromatin-remodeling activities [14]. These epigenetic alterations are responsible for modulation of developmentally-regulated and tissue-specific gene expression [15]. DNA sequences that regulate expression of insulin gene are located within approximately 400 nucleotides upstream of the transcription start site [16] and direct both tissue-specific and metabolic-responsive transcription of the insulin gene. Adjacent to the promoter is a microsatellite variable number tandem repeat (VNTR) region which is also important for insulin gene expression and variability in this region is associated with both type 1 (class I VNTR) and type 2 (class III VNTR) diabetes mellitus [17]. The pathophysiology of type 1 diabetes (T1DM) is the result of the destruction of the insulin-producing beta cells, and a promising treatment paradigm for T1DM is replacement of the missing beta cells with insulin-producing cells derived from embryonic or other stem cell sources. Many groups worldwide are currently working to develop methods to produce beta cells in vitro, however as yet there are no reports demonstrating fully functional cells appropriate for cell replacement therapy. A major hurdle has been achieving normal levels of insulin gene expression.
###end p 12
###begin p 13
###xml 302 307 <span type="species:ncbi:9606">human</span>
###xml 312 317 <span type="species:ncbi:10090">mouse</span>
Although much is known about the control of insulin gene expression, DNA methylation of the insulin promoter and its relationship to gene expression has not been investigated. To understand the role of epigenetic regulation in beta cells, we examined the DNA methylation pattern of the insulin gene in human and mouse beta and non-beta cells and in embryonic stem cells as they differentiate into insulin-expressing cells.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
Beta cell-specific demethylation of the insulin gene
###end title 15
###begin p 16
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 168 176 168 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g001">Figs. 1A</xref>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g002">2A</xref>
###xml 760 767 760 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006953-t001">Table 1</xref>
###xml 854 858 854 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 969 973 969 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Hamaguchi1">[18]</xref>
###xml 1021 1028 1021 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g001">Fig. 1A</xref>
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
###xml 408 413 <span type="species:ncbi:10090">mouse</span>
###xml 651 656 <span type="species:ncbi:10090">mouse</span>
Examination of the mouse Ins2 promoter revealed three CpG dinucleotide sequences located at positions -414, -182, and -171 bp relative to the transcription start site (Figs. 1A and 2A). To test whether these CpG sites have a specific methylation pattern in pancreatic beta cells, we compared the insulin promoter CpG methylation pattern in pancreatic beta cells with various other tissues and with the NIT-1 mouse insulinoma cell line. A portion of the isolated beta cells were immunostained with insulin and glucagon antibodies which showed that more than 70% of the cells were positive for insulin (data not shown). Genomic DNA samples from various mouse tissues, including pancreatic islets, were bisulfite-treated and analyzed by methylation-specific PCR (Table 1) followed by sequencing. The sequencing data revealed that the three CpG sites in the Ins2 promoter are uniquely unmethylated in pancreatic beta cells and in the insulin-producing NIT-1 beta cell line [18] but predominantly methylated in other tissues (Fig. 1A).
###end p 16
###begin title 17
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
###xml 50 55 <span type="species:ncbi:9606">human</span>
Tissue-specific methylation of the mouse Ins2 and human INS promoters.
###end title 17
###begin p 18
###xml 260 264 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 165 170 <span type="species:ncbi:10090">mouse</span>
###xml 254 259 <span type="species:ncbi:10090">mouse</span>
###xml 388 393 <span type="species:ncbi:9606">human</span>
###xml 468 473 <span type="species:ncbi:9606">human</span>
(A) Genomic DNA samples from mouse muscle, liver, kidney, blood, brain, spleen, whole pancreas, partially purified pancreatic beta cells (approximately70%), and the mouse NIT-1 beta cell line were analyzed for tissue specific methylation patterns of the mouse Ins2 promoter (position -480 to +15 bp) which contains three potential methylation sites. (B) Genomic DNA samples obtained from human beta cells ("Islet cell fraction"; approximately70% islet cells) and from human pancreatic exocrine tissue ("Non-islet fraction"; <1% islet cells) were analyzed for methylation of the insulin promoter (-385 - +24 bp), which contains nine CpG sites. Note that 7 of 24 clones (29%) of the clones in the beta cell population exhibited some CpG methylation, consistent with the percentage of non-beta cell contamination.
###end p 18
###begin title 19
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
###xml 58 63 <span type="species:ncbi:9606">human</span>
Methylation suppresses the activity of both the mouse and human insulin gene promoters.
###end title 19
###begin p 20
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 212 216 212 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 275 278 275 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
###xml 324 327 324 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
###xml 555 558 555 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
###xml 999 1003 999 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 1421 1425 1417 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 1613 1617 1609 1613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 318 323 <span type="species:ncbi:9606">human</span>
###xml 549 554 <span type="species:ncbi:9606">human</span>
###xml 993 998 <span type="species:ncbi:10090">mouse</span>
###xml 1607 1612 <span type="species:ncbi:10090">mouse</span>
(A) A diagram of the three luciferase reporter plasmids used to test the effect of methylation on insulin promoter activity. PGL4.10Ins2500bp contains bases -480 to +15 (three CpG sites) of the Ins2 gene, pGL4.10Ins2MP contains bases -169- +15 bp (no CpG sites), and, pGL4.10INS421bp contains bases -385 to +24 of the human INS gene (nine CpG sites). The positions of CpG dinucleotides are represented with "lollipop" markers and the positions of primers for the ChIP experiments by arrows. (B) Methylated (white bar) or mock-methylated (black bar) human INS promoter constructs were transfected into NIT-1 insulinoma cells 48 hours prior to the luciferase assay. The data were normalized with co-transfected control vector and are the average and standard error from three separate experiments of eight replicates each. Data are presented as relative expression compared with the non-methylated, non-stimulated sample. * = p<0.0001 (C) Methylated (white bars) or mock-methylated (black bars) mouse Ins2 promoter constructs were transfected into NIT-1 insulinoma cells and stimulated for four hours with 2.8 mM glucose (Stimulation -) or with 16.7 mM glucose and 10 microM forskolin (Stimulation +). The data were scaled to the unmethylated, unstimulated control. The results are the average and standard error from three separate experiments of eight replicates each. * = p<0.0001 compared with control. (D) The minimal Ins2 promoter construct was treated and analyzed as in 1C. There was no significant effect of methylation or stimulation on minimal promoter activity (one-way ANOVA p = 0.9928). (E) The mouse Ins2 promoter construct was methylated individually at each CpG site (white bars) or mock-methylated (black bar) and then transfected and analyzed as in 1B. The results are the average and standard error from three to five experiments of eight replicates each. * = p<0.0001 compared with control.
###end p 20
###begin title 21
Primers for bisulfite sequencing, reporter constructs, and ChIP assays.
###end title 21
###begin p 22
###xml 194 201 194 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g001">Fig. 1B</xref>
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Lukowiak1">[19]</xref>
###xml 559 562 559 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
###xml 734 738 734 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Todorov1">[20]</xref>
###xml 752 761 752 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g001">Figure 1B</xref>
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 258 263 <span type="species:ncbi:9606">human</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 553 558 <span type="species:ncbi:9606">human</span>
###xml 809 814 <span type="species:ncbi:9606">human</span>
There are nine CpG sequences in the human insulin promoter (-385 to 0 bp) located at positions -357, -345, -234, -206, -180, -135, -102, -69 and -19 bp relative to the transcription start site (Fig. 1B). To map the tissue-specific methylation pattern of the human insulin gene, purified human islets were dissociated and the beta cell fraction was separated from non-beta cells using Newport Green FACS sorting [19]. The enriched beta cell fraction was 70% insulin positive (data not shown) by immunostaining. We compared the methylation pattern of the human INS gene promoter in the beta cell fraction with pancreatic tissue leftover from islet isolation, which is mostly pancreatic acinar cells and contains less than 1% beta cells [20]. As shown in Figure 1B, the insulin promoter in the insulin-producing human beta cell fraction is unmethylated, but it is predominantly methylated in the beta cell depleted fraction.
###end p 22
###begin p 23
###xml 41 46 <span type="species:ncbi:9606">human</span>
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
These results demonstrate that the adult human and mouse insulin gene promoters exhibit a tissue-specific pattern of DNA methylation.
###end p 23
###begin title 24
Methylation suppresses insulin gene expression
###end title 24
###begin p 25
###xml 145 148 145 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
###xml 213 220 213 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g002">Fig. 2A</xref>
###xml 247 251 247 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 306 310 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 323 327 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 421 425 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 435 439 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 517 524 517 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g002">Fig. 2A</xref>
###xml 861 870 861 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g002">Figure 2B</xref>
###xml 897 900 897 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
###xml 1110 1114 1106 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 1162 1169 1158 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g002">Fig. 2C</xref>
###xml 1345 1352 1337 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g002">Fig. 2D</xref>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 241 246 <span type="species:ncbi:10090">mouse</span>
###xml 765 770 <span type="species:ncbi:10090">mouse</span>
###xml 891 896 <span type="species:ncbi:9606">human</span>
###xml 1104 1109 <span type="species:ncbi:10090">mouse</span>
Next, we tested whether methylation affects expression from the insulin gene promoter. A reporter gene construct was made by inserting the human INS promoter into a luciferase expression plasmid (pGL4.10INS421bp; Fig. 2A). Additionally, two mouse Ins2 luciferase reporter constructs were made, one (pGL4.10Ins2500bp) using Ins2 promoter sequences from -480 to +15 bp containing all three CpG sites, and the other (pGL4.10Ins2MP) using Ins2 promoter sequences from -169 to +15 bp which does not contain any CpG sites (Fig. 2A). Each promoter fragment was mock-methylated or methylated with M.SssI CpG methyltransferase prior to insertion into the pGL4.10 luciferase expression plasmid (so that only the promoter fragments were methylated) and then used to transfect mouse NIT-1 cells, which exhibit both basal and stimulated insulin gene expression. As shown in Figure 2B, methylation of the human INS promoter suppressed reporter gene expression in NIT-1 cells about eighty-five percent (1.00+/-0.13 vs. 0.150+/-0.02 RLU; p<0.001). Similarly, CpG methylation significantly suppressed expression from the mouse Ins2 promoter-driven luciferase reporter construct (Fig. 2C; 1.00+/-0.10 vs. .212+/-0.15 RLU; p<0.001). By contrast, the minimal Ins2 promoter, pGL4.10Ins2MP, which lacks the CpG sites, was not affected by methyltransferase treatment (Fig. 2D; 1.00+/-0.31 vs. 0.99+/-0.19 RLU; p = 0.911), although the total activity of the minimal promoter was approximately thirty-fold lower than the full-length promoter.
###end p 25
###begin p 26
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Docherty1">[21]</xref>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Poitout1">[22]</xref>
###xml 365 369 365 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 386 390 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-German1">[23]</xref>
###xml 392 396 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Melloul1">[24]</xref>
###xml 644 648 644 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Hay1">[16]</xref>
###xml 819 823 819 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Seamon1">[25]</xref>
###xml 978 982 978 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 1076 1083 1076 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g002">Fig. 2C</xref>
###xml 1187 1194 1183 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g002">Fig. 2C</xref>
###xml 1264 1268 1256 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 1286 1290 1278 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 1294 1301 1286 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g002">Fig. 2D</xref>
Glucose is the major nutrient regulator of pancreatic beta cell function and coordinately regulates insulin gene transcription, with multiple elements of the promoter involved in glucose responsiveness [21], [22]. The A3, E1, and C1 regions are the major glucose-responsive transcription control elements of the insulin gene and these elements are conserved in the Ins2 promoter region [23], [24]. Of the three CpG sites, the second CpG site at -182 bp of insulin promoter is part of the cyclic adenosine monophosphate (cAMP) responsive element (CRE), which is conserved through many species and is required for maximal insulin gene expression [16]. Forskolin increases intracellular cAMP levels in the beta cell and activates kinases that phosphorylate CRE binding proteins which stimulate CRE-dependent transcription [25]. We therefore tested the effects of a combination of high glucose and forskolin stimulation in reporter assays using methylated or mock-methylated pGL4.10Ins2500bp. Glucose and forskolin treatment significantly stimulated the mock-methylated reporter (Fig. 2C black bars; 1.00+/-0.10 vs. 1.65+/-0.10, p<0.0001), however did not stimulate the methylated reporter (Fig. 2C white bars; 0.21+/-0.04 vs. 0.35+/-0.15, p = 0.385), nor the minimal Ins2 promoter, pGL4.10Ins2MP (Fig. 2D black bars; 1.00+/-0.31 vs. 1.01+/-0.16, p = 0.986). These results indicate that CpG sites and their demethylation status are important for both basal and stimulated insulin gene expression.
###end p 26
###begin p 27
###xml 382 389 382 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g002">Fig. 2E</xref>
###xml 593 597 589 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 627 634 623 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g002">Fig. 2E</xref>
To assess the importance of the individual methylation events on insulin gene expression, reporter plasmids were made in which each CpG site was methylated individually, and then tested for the effects on gene expression. Of the three sites, only methylation of the CpG site within the CRE (-182) was able to independently suppress insulin promoter activity, and only by about 50% (Fig. 2E; 1.00+/-0.08 vs. 0.56+/-0.05, p<0.0001). Methylation of the proximal site (-171) had no effect on gene expression, while methylation of the distal site (-414) paradoxically increased expression from the Ins2 promoter by almost two-fold (Fig. 2E; 1.00+/-0.08 vs. 1.86+/-0.15, p<0.0001). This shows that methylation-dependent suppression of the insulin promoter is not simply additive, and that other mechanisms are likely present in the cell that cooperate with DNA methylation to turn off the insulin gene.
###end p 27
###begin title 28
Methylation indirectly inhibits factor binding to the CRE
###end title 28
###begin p 29
###xml 204 208 204 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Hay2">[26]</xref>
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Iannello1">[27]</xref>
###xml 427 431 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Zhang1">[29]</xref>
###xml 542 546 542 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 597 605 597 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 921 925 921 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Iannello1">[27]</xref>
###xml 927 931 927 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-IguchiAriga1">[28]</xref>
###xml 1019 1026 1019 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g003">Fig. 3A</xref>
###xml 1265 1272 1265 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g003">Fig. 3B</xref>
###xml 1467 1471 1467 1471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 1476 1484 1476 1484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Suppression of gene expression by methylation of the CpG at -182 bp suggested that methylation may regulate the binding of transcription factors to the CRE site. CREB and ATF2 are reported to bind to the Ins2 CRE site and play an important role in insulin transcription [26]. Several studies have demonstrated that CpG methylation of CRE sites suppresses the binding of transcription factors and represses gene expression [27]-[29]. To test the effect of methylation on factors binding to the CRE site, double stranded 24 bp oligomers of the Ins2 promoter CRE site were synthesized and methylated in vitro or mock methylated. Methylation of the oligonucleotides was confirmed by inhibition of AatII restriction digest (not shown). Electrophoretic mobility shift assays (EMSA) were carried out using NIT-1 nuclear extracts to test whether methylation inhibited factor binding to the CRE site. In contrast to other studies [27], [28], we found dose-dependent binding to the CRE site regardless of the methylation status (Fig. 3A). To determine if the factors binding to methylated and unmethylated oligonucleotide were able to be displaced, increasing concentrations of unlabeled oligonucleotide were allowed to compete with the labeled oligonucleotides for binding (Fig. 3B). Both methylated and unmethylated unlabeled oligonucleotides effectively competed with the labeled probes for factor binding, indicating that methylation had no effect on factor binding to the Ins2 CRE in vitro. According to this result, the methylation-dependent repression of insulin gene expression was not due to direct inhibition of transcription factor binding.
###end p 29
###begin title 30
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
Effect of methylation on transcription factor binding to the Ins2 promoter.
###end title 30
###begin p 31
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 640 644 640 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 925 929 925 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 936 943 936 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g003">Fig. 2A</xref>
###xml 1081 1085 1081 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
###xml 634 639 <span type="species:ncbi:10090">mouse</span>
(A) Increasing amounts of NIT-1 nuclear extract was bound to methylated or unmethylated mouse Ins2 promoter CRE oligonucleotide in an Electrophoretic Mobility Shift Assay (EMSA). There was a dose-dependent increase in binding to both the methylated and unmethylated CRE with increasing amounts of NIT-1 cell nuclear extract. (B) The binding of NIT-1 nuclear proteins to one nanomolar of either labeled methylated (mCRE) or unmethylated (CRE) was competed with increasing concentrations of unlabeled CRE or mCRE. The figure is one representative of four experiments. (C) Chromatin immunoprecipitation (ChIP) analysis of the endogenous mouse Ins2 gene promoter in NIT-1 cells. Genomic DNA was immunoprecipitated with anti-CREB, anti-ATF2, anti-MECP2, and control IgG. The results indicate that CREB and ATF2, but not MeCP2, are normally associated with the endogenous insulin promoter. (D) Methylated or mock-methylated pGL4.10Ins2500bp (Fig. 2A) was transfected into NIT-1 cells and then ChIP was carried out with anti-CREB, anti-ATF2, and anti-MeCP2 antibodies. Methylation of the Ins2 promoter decreases the binding of CREB and ATF2, but increases the binding of MeCP2.
###end p 31
###begin p 32
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Meehan1">[30]</xref>
###xml 514 518 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Sharma1">[31]</xref>
###xml 636 640 636 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 685 694 685 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g001">Figure 1A</xref>
###xml 842 851 842 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g003">Figure 3C</xref>
###xml 853 857 853 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Hay2">[26]</xref>
Alternatively, another protein(s) might bind exclusively to the methylated CRE site and regulate Ins2 transcription. The methyl-CpG-binding protein MeCP2 has been reported to bind to methylated CpG motifs [30] in CRE sites, which may block binding of other factors. Additionally, the binding of MeCP2 to methylated DNA sites in gene promoters recruits histone deacetylases, causing deacetylation of histone protein tails and chromatin condensation around the gene promoter, resulting in transcriptional repression [31]. We used chromatin immunoprecipitation (ChIP) experiments to determine the factors binding the CRE in the endogenous Ins2 gene in NIT-1 insulinoma cells. As shown in Figure 1A, this promoter is completely demethylated, and both CREB and ATF2, but not MeCP2, were associated with the endogenous gene as previously reported (Figure 3C) [26].
###end p 32
###begin p 33
###xml 59 66 59 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 199 203 199 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 619 626 619 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g002">Fig. 2A</xref>
###xml 703 707 703 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 906 910 906 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 966 973 966 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g003">Fig. 3D</xref>
###xml 1120 1128 1120 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1425 1429 1425 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-IguchiAriga1">[28]</xref>
To investigate the effect of methylation on factor binding in vivo, ChIP experiments were carried out using methylated or mock methylated reporter plasmids transfected into NIT-1 cells. Whole pGL4.10Ins2500bp plasmid was methylated using M.SssI CpG methyltransferase and methylation status was confirmed by digestion with the methylation-sensitive enzyme HpaII and methylation-insensitive enzyme MspI, and it was also confirmed that DNA methylation did not alter PCR efficiency (data not shown). To avoid background from the endogenous gene, ChIP PCR primers were designed to amplify only the transfected reporter DNA (Fig. 2A). NIT-1 cells were transfected with whole methylated or unmethylated pGL4.10Ins2500bp, cross-linked with formaldehyde, and precipitated with specific antibodies against CREB, ATF2, and MeCP2. The ChIP data shows that CpG methylation inhibited the binding of CREB and ATF2 to the Ins2 promoter CRE site, but increased the binding of MeCP2 (Fig. 3D). Therefore, the binding of the CRE-binding proteins in NIT-1 cells to the insulin promoter is inhibited by methylation inside the cells, but not in vitro. This implies that MeCP2, and possibly other methylated CpG binding proteins, are binding to the methylated promoter and preventing binding of the activators, resulting in a decrease in insulin gene expression. Similar reciprocal binding of CREB and MeCP2 has also been reported by another group [28].
###end p 33
###begin title 34
Insulin gene is demethylated during differentiation of insulin-producing cells
###end title 34
###begin p 35
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-EvansMolina1">[32]</xref>
###xml 356 362 356 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g001">Fig. 1</xref>
###xml 317 322 <span type="species:ncbi:10090">mouse</span>
###xml 342 347 <span type="species:ncbi:9606">human</span>
###xml 963 968 <span type="species:ncbi:10090">mouse</span>
Induction of insulin gene transcription occurs rapidly (<30 min) following glucose stimulation and involves acute changes in chromatin structure [32]. However, in the present study the insulin promoter was demethylated in adult insulin-producing cells even when cells were cultured at normal glucose levels (7 mM for mouse islets, 5.5 mM for human islets; Fig. 1), implying that methylation may not be important for acute regulation of insulin gene expression. Therefore we reasoned that beta cell-specific demethylation may be a developmentally regulated process involved in the differentiation of beta cells. This would mean that either the insulin gene is demethylated in the embryo and becomes preferentially methylated in all cells but the beta cells, or the reverse is true, i.e. the gene is methylated in the embryo and becomes specifically demethylated in beta cells. To evaluate these possibilities, we followed the changes in the methylation pattern as mouse embryonic stem cells differentiated into insulin-expressing cells.
###end p 35
###begin p 36
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Todorov1">[20]</xref>
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-DAmour1">[33]</xref>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Ku1">[34]</xref>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Lee1">[35]</xref>
###xml 573 577 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Gasa1">[36]</xref>
###xml 579 583 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Gu1">[37]</xref>
###xml 980 981 980 981 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1006 1007 1006 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1246 1247 1246 1247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 284 289 <span type="species:ncbi:10090">mouse</span>
###xml 1508 1513 <span type="species:ncbi:10090">mouse</span>
###xml 1546 1551 <span type="species:ncbi:10090">mouse</span>
Many groups are trying to generate insulin-producing beta cells from several types of adult and embryonic cells, however, the conversion ratio to insulin positivity is very low [20], [33]. Our prior studies had succeeded in enriching for insulin-positive cell clusters derived from a mouse embryonic stem cell (mESC) line [34] that has one allele of the neurogenin 3 (Ngn3) gene replaced with Enhanced Green Fluorescent Protein (EGFP) reporter [35]. During development, Ngn3 marks the proendocrine cells of the developing pancreas and is required for their differentiation [36], [37], so this method enriches for cells which are already proceeding down a pathway to hormone expression. In this method, mESC were allowed to differentiate into embryoid bodies (EB) for six days in culture, and then the EB were collected, washed, and cultured in tertiary media for 9 to 11 days. At the end of tertiary culture, the cells were dissociated and FACS-sorted into GFP positive (Ngn3-EGFP+) and negative (Ngn3-EGFP-) populations, representing proendocrine and non-endocrine fractions, respectively. Since the half-life of EGFP transcript is longer than Ngn3, some of the EGFP+ cells may already proceed down a pathway to hormone expression. The Ngn3-EGFP+ population was induced to further differentiate by 3-dimensional culture in extracellular matrix, and colonies of differentiated insulin-expressing cells were handpicked for analysis. Genomic DNA was isolated from cells at each of the six stages and also from mouse liver as a negative control and mouse beta cells and NIT-1 cells as positive controls. The DNA methylation pattern of the insulin promoter in each of these cell populations was determined by pyrosequencing.
###end p 36
###begin p 37
###xml 12 20 12 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g004">Figure 4</xref>
###xml 198 204 198 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g004">Fig. 4</xref>
###xml 266 272 266 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g004">Fig. 4</xref>
###xml 340 341 340 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 372 378 372 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g004">Fig. 4</xref>
###xml 423 427 423 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Ku1">[34]</xref>
###xml 514 522 514 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 540 546 540 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g004">Fig. 4</xref>
###xml 925 933 925 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1008 1013 <span type="species:ncbi:10090">mouse</span>
As shown in Figure 4, the insulin gene promoter in mESC is methylated on all three CpG sites, similar to the liver DNA control. The methylation status is maintained through embryoid body formation (Fig. 4; EB) and endodermal differentiation in the tertiary culture (Fig. 4; FACS presort). Surprisingly, the insulin promoter in the Ngn3-EGFP+ proendocrine cell population (Fig. 4.; FACS (+) sort), which exhibits detectable Ins2 gene expression [34], was still fully methylated. It was not until the final stage of in vitro differentiation (Fig. 4; colonies) that there was significant demethylation of two (-182 and -414) of the three CpG sites. This result shows that complete demethylation of the insulin promoter is a late step in the differentiation of the beta cell phenotype, and is preceded by low level insulin gene expression. It should be noted that the level of insulin gene expression, even in the final stage of in vitro differentiation, is substantially lower than that of fully differentiated mouse beta cells.
###end p 37
###begin title 38
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
Demethylation of the Ins2 promoter during differentiation of mouse embryonic stem cells to insulin-expressing colonies.
###end title 38
###begin p 39
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Ku1">[34]</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 525 530 <span type="species:ncbi:10090">mouse</span>
Mouse embryonic stem cells from Ngn3-EGFP mice were induced to differentiate through several stages into insulin-expressing colonies as previously described [34]. Genomic DNA from each stage was isolated, bisulfite-treated, and the methylation status was determined by pyrosequencing. The methylation status of the three CpG sites is plotted individually: -171 (white), -182 (black), -414 (hatched). The bars represent the averages and standard deviations of three independent stem cell experiments. Genomic DNA samples from mouse liver and purified beta cells were processed in parallel with each experiment as negative and positive controls, respectively. * p<0.05 compared with previous stage.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 212 216 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Docherty1">[21]</xref>
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Poitout1">[22]</xref>
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Melloul1">[24]</xref>
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-EvansMolina1">[32]</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Goodge1">[38]</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Wicksteed1">[39]</xref>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Uchizono1">[40]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Lorenzo1">[41]</xref>
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Youngren1">[42]</xref>
###xml 381 386 <span type="species:ncbi:9606">human</span>
###xml 404 409 <span type="species:ncbi:10090">mouse</span>
The insulin molecule is central to metabolic homeostasis, and as such insulin activity is regulated at multiple levels. Previous studies have established the regulation of insulin activity at the transcriptional [21], [22], [24], post-transcriptional [32], translational [38], [39], secretory [40], and even post-receptor levels [41], [42]. In this study we have demonstrated that human insulin gene and mouse insulin2 gene expression are also controlled epigenetically by methylation of specific CpG sites in the promoter regions. In non-insulin expressing cells, some or all of these sites are methylated, whereas in insulin-expressing cells they are completely demethylated.
###end p 41
###begin p 42
###xml 242 257 242 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g002">Figs. 2B and 2C</xref>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 124 129 <span type="species:ncbi:10090">mouse</span>
###xml 312 317 <span type="species:ncbi:10090">mouse</span>
In general, DNA methylation has a suppressive effect on gene transcription. We show that this is also true of the human and mouse insulin promoters, where complete methylation suppressed reporter gene expression by 85% and 79%, respectively (Figs. 2B and 2C). However, methylation of the individual sites in the mouse promoter revealed only one site, the CpG at position -182, which significantly suppressed gene expression, and only by about 50%. Paradoxically, methylation of the distal CpG at position -414 significantly increased gene expression by 86%. Since complete methylation suppresses insulin promoter activity, these observations imply that methylation-dependent control of insulin gene expression is indirect, probably involving a higher levels of DNA structure such as nucleotide positioning and chromatin compaction.
###end p 42
###begin p 43
###xml 490 494 490 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 842 849 842 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 484 489 <span type="species:ncbi:10090">mouse</span>
The CpG site at position -182 in the mouse Ins2 promoter is located within a cyclic-adenosine monophosphate response element (CRE) which was previously shown to be involved in insulin gene expression. Previous studies have demonstrated that CRE methylation suppresses transcription of other genes, usually by direct inhibition of binding of the transcription factor CREB. Therefore, we investigated the effect of methylation on binding of beta cell factors to the CRE sequence in the mouse Ins2 gene. In agreement with other groups, we found that the transcription factor ATF2 binds to the insulin promoter CRE and that overexpression of ATF2 increases insulin gene expression, whereas CREB overexpression actually suppresses the insulin promoter (data not shown). We also found that binding of both ATF2 and CREB to the insulin promoter CRE in vivo was inhibited by methylation. However, in contrast to other gene promoters, we found that methylation did not directly inhibit transcription factor binding to the CRE in the insulin promoter. Importantly, methylation increased the binding of the methylated DNA binding protein MeCP2. We believe that the binding of MeCP2 to the methylated CpG in the CRE site may compete with binding of other factors, thus contributing to the suppression of gene expression.
###end p 43
###begin p 44
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Wu1">[43]</xref>
###xml 776 780 776 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Francis1">[44]</xref>
###xml 831 835 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Francis2">[45]</xref>
###xml 385 388 <span type="species:ncbi:10116">rat</span>
Yet the predominant suppressive effect of binding of MeCP2 to the insulin gene is probably not due to blocking of transcriptional activators since methylation of the CRE CpG alone results in only 50% inhibition, but rather MeCP2 binding likely recruits histone deacetylases that maintain the chromatin in a compacted state. Wu and Gilbert [43] showed long ago that the promoter of the rat insulin 2 gene exhibits tissue-specific sensitivity to DNase I, indicating a relaxed chromatin structure in this region in insulin-producing cells. More recently the Mirmira laboratory has provided a mechanism for this observation, showing that there is a beta cell-specific shift in nucleosome positioning in the insulin promoter, allowing the binding of the PDX-1 transcription factor [44], which recruits histone methylase to the promoter [45], thus stabilizing the open chromatin structure and providing the opportunity for transcription. We speculate that an initiating event in this process is the beta cell-specific demethylation of the insulin locus resulting in the relaxation of the chromatin structure and repositioning of the nucleosomes.
###end p 44
###begin p 45
###xml 356 364 356 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 640 641 640 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 925 933 925 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1292 1296 1292 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Abu1">[46]</xref>
###xml 1298 1302 1298 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Morgan1">[47]</xref>
###xml 262 267 <span type="species:ncbi:10090">mouse</span>
Therefore, unlike other mechanisms controlling insulin activity, methylation is likely involved in the development of insulin-producing cells rather than in daily metabolic regulation. When one particular developmental model was examined, i.e. the transition of mouse embryonic stem cells to endodermal-like cells and then into an early pancreatic lineage in vitro, it appeared that there is a transition in the insulin promoter from full methylation to partial demethylation. However, decrease in methylation at specific sites occurs very late in the differentiation program and was incomplete in this model, even in the isolated Ngn3-EGFP+ pancreatic endocrine lineage cells. This indicates that demethylation is one of the very late steps in differentiation of insulin-producing cells. This may be one of the reasons that no one has yet been able to achieve efficient differentiation of functional insulin-producing cells in vitro. As yet, the precise mechanism of gene-specific DNA demethylation has not been unraveled. It may be a passive process involving replication in absence of maintenance DNA methylation. Alternatively, recent studies indicate that active DNA demethylation may occur and this pathway may involve interaction between cytosine deaminase and thymine-DNA glycosylase [46], [47]. The developmental control of gene-specific DNA demethylation is the subject of ongoing investigations.
###end p 45
###begin p 46
In conclusion, this study demonstrates that DNA methylation suppresses insulin gene expression and that the insulin gene promoter is specifically demethylated in insulin-producing cells. Methylation recruits MeCP2, and possibly other methylated DNA binding proteins, resulting in decreased binding of the transcriptional activators, ATF2 and CREB. Furthermore, demethylation of the insulin gene appears to be an important and potentially rate-limiting step in the differentiation of insulin-producing cells from embryonic stem cells.
###end p 46
###begin title 47
Materials and Methods
###end title 47
###begin title 48
Ethics Statement
###end title 48
###begin p 49
Animals used in this study received high quality animal care consistent with the Public Health Service Policy on Humane Care and Use of Laboratory Animals, the Guide for the Care and Use of Laboratory Animals, and the Animal Welfare Act. The animal care facility at the City of Hope has been approved by the National Institutes of Health, registered with the U.S. Department of Agriculture, and fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC). The experiments were designed to utilize the minimum number of animals required to obtain valid results.
###end p 49
###begin title 50
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse islet cell preparations
###end title 50
###begin p 51
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">scid</italic>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Pancreata from NODscid or Balb/c mice were digested with 1 mg/ml Liberase (Sigma-Aldrich, St. Louis, MO) for 11 minutes in 37degreesC and then purified islets were separated using Histopaque-1077 (Sigma-Aldrich, St. Louis, MO) followed by hand picking. Isolated islets were cultured overnight and dissociated using Accutase (Innovative Cell Technologies, CA) for 8 minutes and one tenth of the dissociated cells were used for immunocytochemistry to determine purity and composition.
###end p 51
###begin title 52
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human pancreatic beta cell sorting
###end title 52
###begin p 53
###xml 754 755 742 743 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 327 332 <span type="species:ncbi:9606">human</span>
###xml 721 726 <span type="species:ncbi:9606">human</span>
###xml 990 995 <span type="species:ncbi:9606">Human</span>
Human islet cell isolation at the City of Hope National Medical Center was performed with the approval of the Institutional Review Board (IRB# 01083 and 05058). Written informed consent from the donors for research use of tissue in this study was obtained prior to acquisition of the organ. Ten thousand Islet Equivalent (IEQ) human islets from four different donors in independent experiments were incubated with TrypLE (Invitrogen, Carlsbad, CA) at 37degreesC for 15 min. Dissociated islet cells were passed through the 100 and 40 micron strainers. The cells were incubated with 1microM Newport Green (Invitrogen, Carlsbad, CA) at 37degreesC for 1 hour. The cells were resuspended with phosphate buffer containing 0.1% human serum albumin and 2 mM MgCl2. MoFlo High-Performance Cell Sorter (DAKO, Carpinteria, CA, USA) was used for Newport Green positive cell sorting. One tenth of the sorted cells were used for immunocytochemistry and genomic DNA was isolated from the remaining cells. Human non-islet pancreatic tissue containing less than 0.1% islet cells was obtained following the islet isolation procedure by the Southern California-Islet Cell Resource center at the City of Hope.
###end p 53
###begin title 54
Immunocytochemistry
###end title 54
###begin p 55
###xml 232 242 <span type="species:ncbi:10141">guinea pig</span>
###xml 285 291 <span type="species:ncbi:9986">rabbit</span>
Immunocytochemical analyses were performed on cells attached to polylysine-coated coverslips and fixed with 4% paraformaldehyde, cold methanol and acetone. The following primary antibodies were used for immunocytochemical staining: guinea pig anti-insulin (Millipore, St Charles, MO), rabbit anti-glucagon (Millipore, St Charles, MO). Corresponding secondary antibodies against each first antibody/immunoglobulin were either conjugated with fluorescein isothiocyanate (FITC) or Texas red (Jackson Immuno-Research Laboratories, West Grove, PA). Stained samples were embedded in Vectashield (Vector Laboratories, Burlingame, CA) and examined under an Olympus BX51 fluorescent microscope, equipped with a Pixera 600 CL cooled CCD camera (Olympus America, Melville, NY). A picture for each individual color was separately captured using Pixera Viewfinder 3.0 acquisition software (Pixera, Los Gatos, CA). Cell percentages were determined by manual counting of at least six randomly chosen fields.
###end p 55
###begin title 56
Cell culture
###end title 56
###begin p 57
###xml 33 37 33 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Hamaguchi1">[18]</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 176 182 <span type="species:ncbi:9913">bovine</span>
Mouse beta-cell line NIT-1 cells [18] were purchased from American Type Culture Collection (Manassas, VA, USA) and were cultured in Hams F12K media supplemented with 10% fetal bovine serum and antibiotics. Cells were maintained at 37degreesC in a humidified atmosphere containing 95% air and 5% CO2. Cells were passaged by trypsinization and subcultured on a weekly basis. Passage 2 or 3 cells were used for all the experiments.
###end p 57
###begin title 58
Isolation of genomic DNA
###end title 58
###begin p 59
###xml 112 116 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">scid</italic>
###xml 226 230 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">scid</italic>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 455 460 <span type="species:ncbi:9606">human</span>
Genomic DNA was obtained from mice liver, spleen, kidney, brain, muscle, blood, isolated pancreatic islet of NODscid mice or Balb/c mice using ZR genomic DNA kit (Zymo Research, Orange, CA). Tissues were obtained from four NODscid mice and three Balb/c mice for comparing tissue-specific methylation patterns. We observed no strain-specific differences in methylation patterns. TRIzol reagent (Molecular Research Center, Cincinnati, OH, USA) was used for human islet genomic DNA preparation.
###end p 59
###begin title 60
Bisulfite genomic sequencing
###end title 60
###begin p 61
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
###xml 349 353 349 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 437 444 437 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006953-t001">Table 1</xref>
###xml 529 532 529 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 1024 1028 1024 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">scid</italic>
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
###xml 68 73 <span type="species:ncbi:9606">human</span>
###xml 343 348 <span type="species:ncbi:10090">mouse</span>
###xml 362 367 <span type="species:ncbi:9606">human</span>
###xml 1040 1044 <span type="species:ncbi:10090">mice</span>
Nucleotide sequences of the mouse Ins2 gene (GeneID: 16334) and the human INS (GeneID: 3630) gene were obtained from Genbank and the potential methylation sites (i.e. CG dinucleotides) were identified. Genomic DNA samples were treated with EZ DNA methylation kit (Zymo Research, Orange, CA) according to the manufacturer's recommendation. The mouse Ins2 gene or human insulin gene was then amplified with pairs of gene-specific primers (Table 1) in a mixture containing 100 ng bisulfite-modified DNA. PCR was done using Hot Star-Taq polymerase (Qiagen, Valencia, CA). Each PCR fragment was TA cloned into pCR2.1-TOPO vector (Invitrogen, Carlsbad, CA) and transformed with the TOP10-competent cells (Invitrogen, Carlsbad, CA). 5-24 clones of each sample were selected and sequenced with M13F primer or M13R primer. Sequencing was performed by the DNA Sequencing Lab in the Beckman Institute at the City of Hope. There were no discernible strain-specific differences in the tissue-specific methylation patterns between the NODscid and Balb/c mice.
###end p 61
###begin title 62
Construction of reporter gene plasmids
###end title 62
###begin p 63
###xml 178 182 178 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 237 241 237 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 296 300 296 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 321 324 321 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
###xml 382 385 382 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
###xml 493 500 493 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006953-t001">Table 1</xref>
###xml 607 611 607 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Studier1">[48]</xref>
###xml 172 177 <span type="species:ncbi:10090">mouse</span>
###xml 315 320 <span type="species:ncbi:9606">human</span>
pGL4.10-Basic vector (Promega, Madison, WI) was digested with SacI/HindIII and treated with alkaline phosphatase (CIP) (New England BioLabs, Ipswich, MA). Fragments of the mouse Ins2 promoter (-480- +15 bp containing 3 CpG sites (pGL4.10Ins2500bp) and 169- +15 bp containing no CpG sites (pGL4.10Ins2MP) and of the human INS promoter (-385- +24 bp containing nine CpG sites (pGL4.10INS421bp) were amplified by PCR using genomic DNA and primers that added a 3' SacI site and a 5' HindIII site (Table 1). PCR products were inserted into pCR2.1 TOPO vector using TA cloning kit and amplified in ZYM-505 medium [48]. The plasmid sequences were confirmed by DNA sequencing. The cloned promoter fragments were excised and subcloned upstream of the firefly luciferase gene in the pGL4.10-Basic vector (Promega, Madison, WI) using Fastlink ligation kit (Epicentre, Madison, WI, USA) according to the manufacturer's recommendation and transformed into TOP10 competent cells (Invitrogen, Carlsbad, California) for plasmid production.
###end p 63
###begin title 64
###xml 57 62 <span type="species:ncbi:9606">human</span>
In vitro methylation and mock methylation of insulin2 or human insulin promoter
###end title 64
###begin p 65
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 258 262 258 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SssI</italic>
###xml 421 429 421 429 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CG-3&#8242;</named-content>
###xml 489 492 489 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sss</italic>
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Dell1">[49]</xref>
###xml 892 896 892 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 1068 1072 1068 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 1091 1094 1091 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
###xml 129 134 <span type="species:ncbi:9606">human</span>
pCR2.1 plasmids containing the promoter region of Ins2 SacI-480 to +15 bp-HindIII, SacI-169- +15 bp-HindIII, and the promoter of human insulin SacI-385 to +24 bp-HindIII were digested with SacI/HindIII and insert DNA were gel purified and methylated using M.SssI CpG methyltransferase (New England Biolabs, Ipswich, MA), which methylates all cytosine residues within the double-stranded dinucleotide recognition sequence 5'-CG-3'. One microgram promoter DNA was methylated using 10 U of M.SssI CpG methyltransferase, or in a parallel control reaction, mock-methylated in the absence of enzyme. Methylated and mock-methylated plasmids were religated into SacI/HindIII-restricted pGL4.10-Basic vector [49]. The correctly ligated promoter constructs were identified and gel purified, quantitated by spectrophotometry, and confirmed by restriction enzyme digestion prior to transfection. For the Ins2 promoter, the CpG methylated insert was confirmed by digestion with the methylation-sensitive restriction enzyme AatII, which recognizes the GACGTC site at -184-179 bp of Ins2 promoter. For the INS promoter, the CpG methylated insert was confirmed with HpaII and MspI (New England Biolabs, Ipswich, MA). HpaII is a methylation-sensitive restriction endonuclease that cleaves DNA at CCGG sequences when the internal cytosine residue is unmethylated on both strands. MspI cleaves DNA regardless of methylation status of the internal cytosine and serves as a control for digestion efficiency.
###end p 65
###begin title 66
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
Site specific methylation of the Ins2 promoter
###end title 66
###begin p 67
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 126 130 126 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Martinowich1">[50]</xref>
###xml 348 352 348 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 508 546 508 546 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAGAGAGAGCTGGGGACTCGGCTGAGTTAAGA-3&#8242;</named-content>
###xml 571 620 571 620 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTAAGTAGAGGTGTTGACGTCCAAATGAGCGCTTTCTGCAGAC-3&#8242;</named-content>
###xml 814 818 814 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
There are 3 CpG sites in the Ins2 proximal promoter at positions -414, -182, and -171 bp. Site specific methylation of pGL4.10Ins2500bp was carried out with the QuikChange Site Directed Mutagenesis Kit using a protocol adapted from Martinowich et al. [50]. Briefly, methylated primers from sequences around CpG sites -414, -182, and -171 bp of the Ins2 promoter were purchased from IDT (Coralville, IA). The following primers and their reverse complements, containing methylated CpG, were used: -414 bp CpG: 5'-GAGAGAGAGCTGGGGACTCGGCTGAGTTAAGA-3'; -182 and -171 bp CpGs: 5'-CTAAGTAGAGGTGTTGACGTCCAAATGAGCGCTTTCTGCAGAC-3'. Control unmethylated vector was generated using the unmethylated primers for the -182 and -171 bp sequences. PCR was carried out according to the manufacturer's protocol with 100 ng of pGL4.10Ins2500bp per reaction. Following the PCR, the reaction was treated with DpnI for 2 h to remove the template DNA. The product was purified using DNA clean and concentrater-5 (Zymo Research, Orange, CA). DNA concentration was quantitated by gel electrophoresis.
###end p 67
###begin title 68
Transient transfection and luciferase reporter assays
###end title 68
###begin p 69
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 150 154 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 278 285 278 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 740 747 732 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">firefly</italic>
###xml 751 758 743 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 598 604 <span type="species:ncbi:9913">bovine</span>
The unmethylated (mock-methylated), totally methylated, or point methylated Ins2 promoter/firefly luciferase fusion genes, pGL4.10Ins2500bp or pGL4.10Ins2MP were transfected in NIT-1 cells using Fugene 6 (Roche, Indianapolis, IN, USA). In each experiment, the phRL-TK, encoding Renilla luciferase (Promega, Madison, WI), was cotransfected as normalization control. Luminescence was measured 48 h after transfection using the dual-luciferase reporter assay system (Promega, Madison, WI). For stimulation assays, four hours before the assay the medium was replaced with 100 microl RPMI and 10% fetal bovine serum with 2.8 mM glucose or 16.7 mM glucose with 10 microM of forskolin. Reporter activity was normalized by calculating the ratio of firefly to Renilla values. Each construct was tested in three to five independent transfections.
###end p 69
###begin title 70
Electrophoretic Mobility Shift Assays
###end title 70
###begin p 71
###xml 168 176 168 176 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tgaCGtcc</underline>
###xml 156 197 156 197 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-tagaggtgt<underline>tgaCGtcc</underline>aatgagCGctttctgcag-3&#8242;</named-content>
###xml 231 239 231 239 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ggaCGtca</underline>
###xml 210 251 210 251 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ctgcagaaagCGctcatt<underline>ggaCGtca</underline>acacctcta-3&#8242;</named-content>
###xml 760 764 760 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Schreiber1">[51]</xref>
###xml 810 811 810 811 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
Sense and antisense strand oligonucleotides corresponding to positions -194 to -160 of the mouse Ins2 promoter and containing CRE and two CpG sites (sense: 5'-tagaggtgttgaCGtccaatgagCGctttctgcag-3'; antisense: 5'-ctgcagaaagCGctcattggaCGtcaacacctcta-3'; CpG sites are capitalized, the CRE is underlined) were synthesized by IDT. The oligonucleotides were labeled with biotin at the 3'-end using the Pierce Biotin 3' End DNA Labeling Kit (Rockford, IL, USA), then annealed, and an aliquot was methylated using M.SssI CpG methylase (New England Biolabs, Ipswich, MA). The methylation status of the oligonucleotide was confirmed by CpG methylation sensitive restriction digest with AatII. Nuclear extracts of NIT-1 cells were prepared according to Schreiber et al [51] with the addition of 1 mM NaF and 0.2 mM NaVO4, and the protein concentration determined using the BioRad Protein Assay (Hercules, CA, USA). Methylated or unmethylated oligonucleotides (20 fmol) were mixed with 2-8 microg NIT-1 nuclear protein in 20 microl of 15 mM Tris-HCl, 50 mM KCl, 0.1 mM EDTA, 1 mM DTT, 0.1 mg/ml BSA, 10% glycerol, 0.05% NP40, 0.5 microM biotin, and 0.1 mg/ml poly-(dIdC) and incubated for 30 minutes at room temperature. Binding was assessed by separation on 6% polyacrylamide/0.5x TBE gels, transfer to nylon membranes, and detection with LightShift Chemiluminescent EMSA reagents (Pierce, Rockford, IL, USA).
###end p 71
###begin title 72
Transfected plasmid ChIP
###end title 72
###begin p 73
###xml 7 11 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 367 371 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 852 855 832 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 1387 1394 1333 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006953-g002">Fig. 2A</xref>
###xml 1399 1406 1345 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006953-t001">Table 1</xref>
###xml 615 620 <span type="species:ncbi:10090">mouse</span>
###xml 659 665 <span type="species:ncbi:9986">rabbit</span>
###xml 722 728 <span type="species:ncbi:9986">rabbit</span>
pGL4.10Ins2500bp (40 microg) was treated with M.SssI (60 U) overnight in 37degreesC. The unmethylated and methylated plasmids (200 ng) were digested with 20 U of either HpaII or MspI at 37degreesC overnight to confirm the methylation status. NIT-1 cells growing on 3x10-cm culture dishes were transfected with 18 microg of whole CpG methylated or unmethylated pGL4.10Ins2500bp using Fugene6 transfection reagent. Chromatin immunoprecipitation (ChIP) was carried out using enzymatic shearing method kit (Active Motif, Carlsbad, CA, USA) according to the manufacturer's recommendations with the following antibodies: mouse anti-CREB (Invitrogen, Carlsbad, CA), rabbit polyclonal anti-ATF2 (Santa-Cruz, Santa Cruz, CA, USA), rabbit polyclonal anti-MeCP2 (Upstate, Chicago, IL, USA). Amplification of the immunoprecipitated DNA was achieved using Hot Star Taq DNA polymerase and 5 microl of either immunoprecipitated DNA, or a 1:10 dilution of input chromatin. Experimental reactions were performed to determine optimal PCR conditions so that the yield of PCR products was dependent on the amount of input DNA (data not shown). The conditions for all reactions were as follows: 94degreesC for 15 min, followed by 32 cycles at 94degreesC for 30 seconds, 61degreesC for 30 seconds, 72degreesC for 1 min, and 72degreesC for 10 min. Primers were designed to amplify only reporter construct DNA (Fig. 2A and Table 1). PCR products were electrophoresed on 2% agarose gels and stained with ethidium bromide.
###end p 73
###begin title 74
Genomic ChIP
###end title 74
###begin p 75
###xml 169 175 <span type="species:ncbi:9986">rabbit</span>
NIT-1 cells growing on 3x10-cm culture dishes were used for genomic ChIP. ChIP was carried out with the same antibodies utilized in the plasmid ChIP. The normal control rabbit IgG (Alpha Diagnostic, Carlsbad, CA, USA) was used for the negative control. The conditions for all reactions were as follows: 94degreesC for 15 min, followed by 33 cycles at 94degreesC for 30 seconds, 63degreesC for 30 seconds, 72degreesC for 1 min, and 72degreesC for 10 min.
###end p 75
###begin title 76
Pyrosequencing
###end title 76
###begin p 77
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006953-Ku1">[34]</xref>
###xml 204 208 204 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ins2</italic>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse embryonic stem cell were differentiated and sorted and cultured as previously described [34], and genomic DNA from samples at each stage were isolated and bisulfite converted. Pyrosequencing of the Ins2 promoter region was done by EpigenDX (Worcester, MA) using 5'-biotinylated primer sets. Liver and beta cell bisulfite treated genomic DNA PCR were analyzed simultaneously as negative and positive controls, respectively. The percentages of methylation at each CpG site in the Ins2 promoter are shown for each stage of differentiation.
###end p 77
###begin title 78
References
###end title 78
###begin article-title 79
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
Characterization of the two nonallelic genes encoding mouse preproinsulin.
###end article-title 79
###begin article-title 80
Isolation and characterization of proinsulin-producing medullary thymic epithelial cell clones.
###end article-title 80
###begin article-title 81
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
Tissue- and developmental stage-specific imprinting of the mouse proinsulin gene, Ins2.
###end article-title 81
###begin article-title 82
An enhancer deletion affects both H19 and Igf2 expression.
###end article-title 82
###begin article-title 83
Knock-in of diphteria toxin A chain gene at Ins2 locus: effects on islet development and localization of Ins2 expression in the brain.
###end article-title 83
###begin article-title 84
###xml 42 47 <span type="species:ncbi:9606">human</span>
Evidence that insulin is imprinted in the human yolk sac.
###end article-title 84
###begin article-title 85
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
Multiple mechanisms regulate imprinting of the mouse distal chromosome 7 gene cluster.
###end article-title 85
###begin article-title 86
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Imprinting at the mouse Ins2 locus: evidence for cis- and trans-allelic interactions.
###end article-title 86
###begin article-title 87
###xml 18 23 <span type="species:ncbi:9606">human</span>
Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus.
###end article-title 87
###begin article-title 88
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
Developmental control of allelic methylation in the imprinted mouse Igf2 and H19 genes.
###end article-title 88
###begin article-title 89
###xml 48 53 <span type="species:ncbi:9606">human</span>
Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region.
###end article-title 89
###begin article-title 90
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
###end article-title 90
###begin article-title 91
###xml 20 25 <span type="species:ncbi:9606">human</span>
DNA methylation and human disease.
###end article-title 91
###begin article-title 92
Environmental epigenomics and disease susceptibility.
###end article-title 92
###begin article-title 93
The role of mammalian DNA methyltransferases in the regulation of gene expression.
###end article-title 93
###begin article-title 94
Comparative analysis of insulin gene promoters: implications for diabetes research.
###end article-title 94
###begin article-title 95
Role of beta-cells in type 1 diabetes pathogenesis.
###end article-title 95
###begin article-title 96
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse.
###end article-title 96
###begin article-title 97
###xml 46 51 <span type="species:ncbi:9606">human</span>
Identification and purification of functional human beta-cells by a new specific zinc-fluorescent probe.
###end article-title 97
###begin article-title 98
###xml 14 19 <span type="species:ncbi:9606">human</span>
Generation of human islets through expansion and differentiation of non-islet pancreatic cells discarded (pancreatic discard) after islet isolation.
###end article-title 98
###begin article-title 99
Nutrient regulation of insulin gene expression.
###end article-title 99
###begin article-title 100
Regulation of the insulin gene by glucose and fatty acids.
###end article-title 100
###begin article-title 101
The insulin gene promoter. A simplified nomenclature.
###end article-title 101
###begin article-title 102
Regulation of insulin gene transcription.
###end article-title 102
###begin article-title 103
Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells.
###end article-title 103
###begin article-title 104
###xml 21 26 <span type="species:ncbi:9606">human</span>
ATF-2 stimulates the human insulin promoter through the conserved CRE2 sequence.
###end article-title 104
###begin article-title 105
Methylation-dependent silencing of the testis-specific Pdha-2 basal promoter occurs through selective targeting of an activating transcription factor/cAMP-responsive element-binding site.
###end article-title 105
###begin article-title 106
CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation.
###end article-title 106
###begin article-title 107
###xml 120 125 <span type="species:ncbi:9606">human</span>
Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues.
###end article-title 107
###begin article-title 108
Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA.
###end article-title 108
###begin article-title 109
Chromatin, DNA methylation and neuron gene regulation-the purpose of the package.
###end article-title 109
###begin article-title 110
###xml 76 81 <span type="species:ncbi:9606">human</span>
Glucose regulation of insulin gene transcription and pre-mRNA processing in human islets.
###end article-title 110
###begin article-title 111
###xml 65 70 <span type="species:ncbi:9606">human</span>
Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells.
###end article-title 111
###begin article-title 112
###xml 43 49 <span type="species:ncbi:10090">murine</span>
Insulin-expressing colonies developed from murine embryonic stem cell-derived progenitors.
###end article-title 112
###begin article-title 113
Neurogenin 3 is essential for the proper specification of gastric enteroendocrine cells and the maintenance of gastric epithelial cell identity.
###end article-title 113
###begin article-title 114
Proendocrine genes coordinate the pancreatic islet differentiation program in vitro.
###end article-title 114
###begin article-title 115
Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors.
###end article-title 115
###begin article-title 116
Translational regulation of proinsulin biosynthesis and proinsulin conversion in the pancreatic beta-cell.
###end article-title 116
###begin article-title 117
Glucose-induced translational control of proinsulin biosynthesis is proportional to preproinsulin mRNA levels in islet beta-cells but not regulated via a positive feedback of secreted insulin.
###end article-title 117
###begin article-title 118
The balance between proinsulin biosynthesis and insulin secretion: where can imbalance lead?
###end article-title 118
###begin article-title 119
Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes.
###end article-title 119
###begin article-title 120
Regulation of insulin receptor function.
###end article-title 120
###begin article-title 121
###xml 74 77 <span type="species:ncbi:10116">rat</span>
Tissue-specific exposure of chromatin structure at the 5' terminus of the rat preproinsulin II gene.
###end article-title 121
###begin article-title 122
Role of chromatin accessibility in the occupancy and transcription of the insulin gene by the pancreatic and duodenal homeobox factor 1.
###end article-title 122
###begin article-title 123
Pdx-1 links histone H3-Lys-4 methylation to RNA polymerase II elongation during activation of insulin transcription.
###end article-title 123
###begin article-title 124
###xml 17 22 <span type="species:ncbi:9606">human</span>
The main role of human thymine-DNA glycosylase is removal of thymine produced by deamination of 5-methylcytosine and not removal of ethenocytosine.
###end article-title 124
###begin article-title 125
Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming.
###end article-title 125
###begin article-title 126
Protein production by auto-induction in high density shaking cultures.
###end article-title 126
###begin article-title 127
In vitro methylation of specific regions in recombinant DNA constructs by excision and religation.
###end article-title 127
###begin article-title 128
DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation.
###end article-title 128
###begin article-title 129
Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.
###end article-title 129
###begin p 130
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 130
###begin p 131
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by a grant from the Nora Eccles Treadwell Foundation, grant 1-2008-1009 from the Juvenile Diabetes Research Foundation, and NIH grants U42 RR16607 and DK056952. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 131

